5 Questions With Angela Stoyanovitch, B.A., LATG, Founding Partner & Podcast Host, Legal Drugs Agency and Director of Business Development, USA, for Metrion Biosciences

Published on :

5 Questions With Angela Stoyanovitch, B.A., LATG, Founding Partner & Podcast Host, Legal Drugs Agency and Director of Business Development, USA, for Metrion Biosciences

5 Questions with Stephen Tyrpak, Associate VP of Medical Device Operations & Associate Partner at PQE Group

Published on :

Stephen Tyrpak is a healthcare executive and commercialization expert with over 14 years’ experience working with medical devices, pharmaceuticals and combination products. He has worked with companies from 5-5,000+ employees and has focused many of his efforts in supporting startup companies. He works for the PQE Group, a global consulting firm with 25 years of success, with more than 2,000 employees located in  32 offices around the globe. He is the Associate VP of Medical Device Operations – US & Canada, and Associate Partner.

5 Questions With Charlie Yowell, PE, Principal and Branch Manager at Bohler

Published on :

As Principal and Branch Manager of Bohler’s Raleigh, North Carolina office, where life sciences development is booming, Charlie has designed and permitted more than two million square feet of life sciences, research and development, laboratory, and manufacturing space. Understanding the varying operations and utility demands of different tenants and end users, as well as zoning, redevelopment, and conversion challenges, Charlie’s team guides developers in creating highly flexible and marketable life sciences facilities, bringing them to market fast.

BioBuzz’s 2022 Top 5 “5 Questions With…”

Published on :

We at BioBuzz have always strived to center ourselves around the individuals who have worked to push the biohealth sphere to new heights. Our “5 Questions With…” series embodies this effort as we have highlighted professionals at all levels, from early career to the C-suite, from scientists to business developers to managers and directors. Regardless of position or title, the many individuals highlighted in 2022 are all changemakers in their own right and we greatly appreciate their work and contribution to this series.